Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study.

MLA

Furtado, Felipe S., et al. “Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: A Retrospective Cohort Study.” Molecular Imaging & Biology, vol. 23, no. 3, June 2021, pp. 456–66. EBSCOhost, https://doi.org/10.1007/s11307-020-01569-7.

APA

Furtado, F. S., Ferrone, C. R., Lee, S. I., Vangel, M., Rosman, D. A., Weekes, C., Qadan, M., Fernandez-Del Castillo, C., Ryan, D. P., Blaszkowsky, L. S., Hong, T. S., Clark, J. W., Striar, R., Groshar, D., Cañamaque, L. G., Umutlu, L., & Catalano, O. A. (2021). Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study. Molecular Imaging & Biology, 23(3), 456–466. https://doi.org/10.1007/s11307-020-01569-7

Chicago

Furtado, Felipe S., Cristina R. Ferrone, Susanna I. Lee, Mark Vangel, David A. Rosman, Colin Weekes, Motaz Qadan, et al. 2021. “Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: A Retrospective Cohort Study.” Molecular Imaging & Biology 23 (3): 456–66. doi:10.1007/s11307-020-01569-7.